Fed. Circ. Upholds Invalidity Of Purdue's Sleep Aid Patents
Law360, New York (January 8, 2016, 12:37 PM EST) -- The Federal Circuit on Friday upheld a New Jersey district court’s ruling in favor of Actavis Elizabeth LLC and other drugmakers finding that three of Purdue Pharmaceutical Products LP’s patents for the sleep aid Intermezzo are invalid because they were obvious.
In a one-line order, the circuit court shot down Purdue and co-appellant Transcept Pharmaceuticals Inc.’s arguments that the patents were for a different dosage of sleep medication than other insomnia drugs on the market at the time.
U.S. Circuit Judges Alan D. Lourie, Timothy B. Dyk and Todd M. Hughes agreed with U.S. District Judge Jose L. Linares' March decision, which...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.